Area of research
Molecular Biology · Immunology
Research interest
Research interests include Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Chronic Kidney Disease and Diabetes, Metabolomics and Mass Spectrometry Studies, and Nitric Oxide and Endothelin Effects.
Sphingolipids and Mortality in Hemodialysis: Innocent Bystanders or Causal Culprits?
Chronic kidney disease induces distinct alterations of macrophage lipid metabolism in a mouse model of atherosclerosis.
Leveraging complementary multi-omics data integration methods for mechanistic insights in kidney diseases
Limitations in PPARα-dependent mitochondrial programming restrain the differentiation of human stem cell-derived β cells.
High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease.
Accelerated osteocytic citrate production in chronic kidney disease is associated with protection of the kidney
Fatty acids and inflammatory stimuli induce expression of long-chain acyl-CoA synthetase 1 to promote lipid remodeling in diabetic kidney disease.
Tubular dysfunction impairs renal excretion of pseudouridine in diabetic kidney disease.
Cross-Sectional Associations between Prenatal Per- and Poly-Fluoroalkyl Substances and Bioactive Lipids in Three Environmental Influences on Child Health Outcomes (ECHO) Cohorts.
SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes
SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes.
The deacylase sirtuin 5 reduces malonylation in nonmitochondrial metabolic pathways in diabetic kidney disease
Inhibition of neutrophil extracellular trap formation alleviates vascular dysfunction in type 1 diabetic mice.
Associations of phthalates, phthalate replacements, and their mixtures with eicosanoid biomarkers during pregnancy
Dietary interventions improve diabetic kidney disease, but not peripheral neuropathy, in a <i>db/db</i> mouse model of type 2 diabetes
Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients.
Developmental programming: Impact of preconceptional and gestational exposure to a real-life environmental chemical mixture on maternal steroid, cytokine and oxidative stress milieus in sheep.
Dietary interventions improve diabetic kidney disease, but not peripheral neuropathy, in a db/db mouse model of type 2 diabetes.
Tubular dysfunction impairs renal excretion of pseudouridine in diabetic kidney disease
Role of succinate in airway epithelial cell regulation following traumatic lung injury.
Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease.
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19.
Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.
Present and future directions in diabetic kidney disease.
Unsupervised machine learning for identifying important visual features through bag-of-words using histopathology data from chronic kidney disease.
Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes.
Multi-Scalar Data Integration Links Glomerular Angiopoietin-Tie Signaling Pathway Activation With Progression of Diabetic Kidney Disease
Multi-Scalar Data Integration Links Glomerular Angiopoietin-Tie Signaling Pathway Activation With Progression of Diabetic Kidney Disease.
Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies